Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Recombinant exendin 4 - Uni-Bio Science Group

Next Previous
Drug Profile

Recombinant exendin 4 - Uni-Bio Science Group

Alternative Names: Recombinant exendin-4 - Uni-Bio Science Group; Uni rE4; Uni-E4; Uni-E4-Fc

Latest Information Update: 21 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Uni-Bio Science Group
  • Class Antihyperglycaemics; Obesity therapies; Peptides; Venoms
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 21 Oct 2021 Discontinued - Phase-I for Type 2 diabetes mellitus in China (SC) (Uni-Bio Science Group pipeline, October 2021)
  • 21 Oct 2021 Discontinued - Phase-III for Type 2 diabetes mellitus in China (SC) (Uni-Bio Science Group pipeline, October 2021)
  • 22 Aug 2018 Uni-Bio Science Group plans a phase III trial for Type-2 diabetes mellitus first half of 2019

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top